These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8420422)

  • 21. Damage to surfactant-specific protein in acute respiratory distress syndrome.
    Baker CS; Evans TW; Randle BJ; Haslam PL
    Lancet; 1999 Apr; 353(9160):1232-7. PubMed ID: 10217084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of the adult respiratory distress syndrome. What have we learned from human studies?
    Fein A; Wiener-Kronish JP; Niederman M; Matthay MA
    Crit Care Clin; 1986 Jul; 2(3):429-53. PubMed ID: 3331557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in subphase aggregates in rabbits injured by free fatty acid.
    Hall SB; Hyde RW; Notter RH
    Am J Respir Crit Care Med; 1994 May; 149(5):1099-106. PubMed ID: 8173747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
    Playfor SD; Nootigattu VK
    Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant supplementation in the lung.
    Anzueto A
    Respir Care Clin N Am; 2002 Jun; 8(2):211-36. PubMed ID: 12481816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant in adult respiratory distress syndrome.
    Mason RJ
    Eur J Respir Dis Suppl; 1987; 153():229-36. PubMed ID: 3322863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
    Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
    Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary surfactant: functions, abnormalities and therapeutic options.
    Frerking I; Günther A; Seeger W; Pison U
    Intensive Care Med; 2001 Nov; 27(11):1699-717. PubMed ID: 11810113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The adult respiratory distress syndrome: first trials with surfactant replacement.
    Richman PS; Spragg RG; Robertson B; Merritt TA; Curstedt T
    Eur Respir J Suppl; 1989 Mar; 3():109s-111s. PubMed ID: 2742681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients].
    Kozlov IA; Poptsov VN
    Anesteziol Reanimatol; 2005; (6):38-41. PubMed ID: 16499105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant abnormalities in patients with respiratory failure after multiple trauma.
    Pison U; Seeger W; Buchhorn R; Joka T; Brand M; Obertacke U; Neuhof H; Schmit-Neuerburg KP
    Am Rev Respir Dis; 1989 Oct; 140(4):1033-9. PubMed ID: 2802366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
    Zhu GF; Sun B; Niu SF; Cai YY; Lin K; Lindwall R; Robertson B
    Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis.
    Walmrath D; Günther A; Ghofrani HA; Schermuly R; Schneider T; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1996 Jul; 154(1):57-62. PubMed ID: 8680699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic approach to a child with acute respiratory distress syndrome: a report of two cases.
    Nosal S; Durdik P; Luptakova A; Sutovska M; Nosal V; Jesenak M; Havlicekova Z; Hamzik J; Banovcin P
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():43-51. PubMed ID: 19218632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanical ventilation in the management of acute respiratory distress syndrome.
    Delong P; Murray JA; Cook CK
    Semin Dial; 2006; 19(6):517-24. PubMed ID: 17150053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis.
    Raymondos K; Leuwer M; Haslam PL; Vangerow B; Ensink M; Tschorn H; Schürmann W; Husstedt H; Rueckoldt H; Piepenbrock S
    Crit Care Med; 1999 Jan; 27(1):82-9. PubMed ID: 9934898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy.
    Taeusch HW
    Biol Neonate; 2000 May; 77 Suppl 1():2-8. PubMed ID: 10828579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of exogenous surfactant to treat patients with acute high-permeability lung edema.
    Spragg RG; Richman P; Gilliard N; Merritt TA; Robertson B; Curstedt T
    Prog Clin Biol Res; 1989; 308():791-6. PubMed ID: 2675070
    [No Abstract]   [Full Text] [Related]  

  • 39. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
    Taeusch HW; Keough KM
    Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury.
    Lewis JF; McCaig L
    Am Rev Respir Dis; 1993 Nov; 148(5):1187-93. PubMed ID: 8239152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.